Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy

Bibliography

• Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004;40(6):1275-84
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7
   PubMed Web of Science ®Google Scholar
• Resende RR, da Costa JL, Kihara AH, et al. Intracellular Ca2+ regulation during neuronal differentiation of murine embryonal carcinoma and mesenchymal stem cells. Stem Cells Dev 2010;19(3):379-94
   PubMed Web of Science ®Google Scholar
• Glenn JD, Whartenby KA. Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells 2014;6(5):526-39
   PubMedGoogle Scholar
• Friedenstein AJ, Piatetzky SII, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16(3):381-90
   PubMedGoogle Scholar
• Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109(1):235-42
   PubMed Web of Science ®Google Scholar
• Ishige I, Nagamura-Inoue T, Honda MJ, et al. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord. Int J Hematol 2009;90(2):261-9
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211-28
   PubMedGoogle Scholar
• Yan K, Zhang R, Chen L, et al. Nitric oxide-mediated immunosuppressive effect of human amniotic membrane-derived mesenchymal stem cells on the viability and migration of microglia. Brain Res 2014;1590:1-9
   PubMed Web of Science ®Google Scholar
• In ’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22(7):1338-45
   PubMed Web of Science ®Google Scholar
• Ryu KH, Kim SY, Kim YR, et al. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Exp Cell Res 2014;326(1):143-54
   PubMed Web of Science ®Google Scholar
• Ponnaiyan D, Bhat KM, Bhat GS. Comparison of immuno-phenotypes of stem cells from human dental pulp and periodontal ligament. Int J Immunopathol Pharmacol 2012;25(1):127-34
   PubMed Web of Science ®Google Scholar
• Lai D, Wang F, Dong Z, Zhang Q. Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model. PLoS One 2014;9(5):e98749
   PubMed Web of Science ®Google Scholar
• in ’t Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88(8):845-52
   PubMedGoogle Scholar
• Joshi M, B Patil P, He Z, et al. Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes. Cytotherapy 2012;14(6):657-69
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-17
   PubMed Web of Science ®Google Scholar
• Thirumala S, Goebel WS, Woods EJ. Manufacturing and banking of mesenchymal stem cells. Expert Opin Biol Ther 2013;13(5):673-91
   PubMed Web of Science ®Google Scholar
• Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C. Mesenchymal stem cells derived from Wharton’s Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther 2013;8(2):144-55
   PubMed Web of Science ®Google Scholar
• Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001;82(4):583-90
   PubMed Web of Science ®Google Scholar
• Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006;91(8):1017-26
   PubMed Web of Science ®Google Scholar
• Vawda R, Fehlings MG. Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives. Curr Stem Cell Res Ther 2013;8(1):25-38
   PubMed Web of Science ®Google Scholar
• Vellasamy S, Sandrasaigaran P, Vidyadaran S, et al. Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J Stem Cells 2012;4(6):53-61
   PubMedGoogle Scholar
• Pikula M, Marek-Trzonkowska N, Wardowska A, et al. Adipose tissue-derived stem cells in clinical applications. Expert Opin Biol Ther 2013;13(10):1357-70
   PubMed Web of Science ®Google Scholar
• Fong CY, Chak LL, Biswas A, et al. Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev 2011;7(1):1-16
   PubMed Web of Science ®Google Scholar
• Hsieh JY, Fu YS, Chang SJ, et al. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton’s jelly of umbilical cord. Stem Cells Dev 2010;19(12):1895-910
   PubMed Web of Science ®Google Scholar
• Cho PS, Messina DJ, Hirsh EL, et al. Immunogenicity of umbilical cord tissue derived cells. Blood 2008;111(1):430-8
   PubMed Web of Science ®Google Scholar
• Deuse T, Stubbendorff M, Tang-Quan K, et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 2011;20(5):655-67
   PubMed Web of Science ®Google Scholar
• Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton’s jelly of the human umbilical cord. Stem Cell Rev 2013;9(2):226-40
   PubMed Web of Science ®Google Scholar
• Mennan C, Wright K, Bhattacharjee A, et al. Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Bio Med Res Intern 2013;2013:916136
   Google Scholar
• Han YF, Tao R, Sun TJ, et al. Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology 2013;65(5):819-27
   PubMed Web of Science ®Google Scholar
• Salehinejad P, Alitheen NB, Ali AM, et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cell Dev Biol Anim 2012;48(2):75-83
   PubMed Web of Science ®Google Scholar
• Conconi MT, Burra P, Di Liddo R, et al. CD105(+) cells from Wharton’s jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 2006;18(6):1089-96
   PubMed Web of Science ®Google Scholar
• Balci D, Can A. The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking. Curr Stem Cell Res Ther 2013;8(1):60-72
   PubMedGoogle Scholar
• Ullah I, Baregundi Subbarao R, Rho GJ. Human Mesenchymal Stem Cells - Current trends and future prospective. Biosci Rep 2015;35(2):e00191
   PubMed Web of Science ®Google Scholar
• Matsumura K, Hayashi F, Nagashima T, Hyon SH. Long-term cryopreservation of human mesenchymal stem cells using carboxylated poly-l-lysine without the addition of proteins or dimethyl sulfoxide. J Biomater Sci Polymer Ed 2013;24(12):1484-97
   PubMed Web of Science ®Google Scholar
• de Lima Prata K, de Santis GC, Orellana MD, et al. Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions. Cytotherapy 2012;14(6):694-700
   PubMed Web of Science ®Google Scholar
• Mazur P. Kinetics of water loss from cells at subzero temperatures and the likelihood of intracellular freezing. J Gen Physiol 1963;47:347-69
   PubMed Web of Science ®Google Scholar
• Jin JL, Liu Z, Lu ZJ, et al. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res 2013;10(1):11-20
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang Z, Xu R, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med 2012;1(10):725-31
   PubMed Web of Science ®Google Scholar
• Kong D, Zhuang X, Wang D, et al. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin Lab 2014;60(12):1969-76
   PubMed Web of Science ®Google Scholar
• Liu WW, Yu W, Chen JY, et al. Effects of human umbilical cord mesenchymal stem cells in the treatment of paraquat-induced lung injury. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012;30(11):811-15
   PubMedGoogle Scholar
• Fang TC, Pang CY, Chiu SC, et al. Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One 2012;7(9):e46504
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang Z, Zheng X, et al. Haploidentical hematopoietic stem cell transplant with umbilical cord-derived multipotent mesenchymal cell infusion for the treatment of high-risk acute leukemia in children. Leuk Lymphoma 2014;1-7
   Google Scholar
• Suzuki K, Sun R, Origuchi M, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med 2011;17(7-8):579-87
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Brenner M, Fibbe WE, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010;12(5):576-8
   PubMed Web of Science ®Google Scholar
• Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 2012;7(10):e47559
   PubMed Web of Science ®Google Scholar
• Gauthaman K, Yee FC, Cheyyatraivendran S, et al. Human umbilical cord Wharton’s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem 2012;113(6):2027-39
   PubMed Web of Science ®Google Scholar
• Ayuzawa R, Doi C, Rachakatla RS, et al. Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett 2009;280(1):31-7
   PubMed Web of Science ®Google Scholar
• Gauthaman K, Fong CY, Arularasu S, et al. Human Wharton’s jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice. J Cell Biochem 2013;114(2):366-77
   PubMed Web of Science ®Google Scholar
• Matsuzuka T, Rachakatla RS, Doi C, et al. Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. Lung Cancer 2010;70(1):28-36
   PubMed Web of Science ®Google Scholar
• Zhang J, Chopp M. Cell-based therapy for ischemic stroke. Expert Opin Biol Ther 2013;13(9):1229-40
   PubMed Web of Science ®Google Scholar
• Troyer DL, Weiss ML. Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells 2008;26(3):591-9
   PubMed Web of Science ®Google Scholar
• Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 2012;11(4):369-80
   PubMed Web of Science ®Google Scholar
• Mora-Lee S, Sirerol-Piquer MS, Gutierrez-Perez M, et al. Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One 2012;7(8):e43683
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhu W, Zhu J, et al. Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplant 2013;22(12):2291-8
   PubMed Web of Science ®Google Scholar
• Chen L, Xi H, Huang H, et al. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke. Cell Transplant 2013;22(Suppl 1):S83-91
   PubMedGoogle Scholar
• Hu SL, Luo HS, Li JT, et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit Care Med 2010;38(11):2181-9
   PubMed Web of Science ®Google Scholar
• Erdogan B, Bavbek M, Sahin IF, et al. Fetal allogeneic umbilical cord cell transplantation improves motor function in spinal cord-injured rats. Turk Neurosurg 2010;20(3):286-94
   PubMed Web of Science ®Google Scholar
• Shang AJ, Hong SQ, Xu Q, et al. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res 2011;1391:102-13
   PubMed Web of Science ®Google Scholar
• Schira J, Gasis M, Estrada V, et al. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain 2012;135(Pt 2):431-46
   PubMed Web of Science ®Google Scholar
• Liu J, Han D, Wang Z, et al. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy 2013;15(2):185-91
   PubMed Web of Science ®Google Scholar
• Lu Z, Ye D, Qian L, et al. Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica. Curr Neurovasc Res 2012;9(4):250-5
   PubMed Web of Science ®Google Scholar
• Liang J, Zhang H, Hua B, et al. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 2009;15(5):644-6
   PubMed Web of Science ®Google Scholar
• Hou ZL, Liu Y, Mao XH, et al. Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis. Cell Adh Migr 2013;7(5):404-7
   PubMed Web of Science ®Google Scholar
• Li JF, Zhang DJ, Geng T, et al. The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis. Cell Transplant 2014;23(Suppl 1):S113-22
   PubMed Web of Science ®Google Scholar
• Dongmei H, Jing L, Mei X, et al. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy 2011;13(8):913-17
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99(10):3838-43
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105(4):1815-22
   PubMed Web of Science ®Google Scholar
• Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 2010;5(4):e10088
   PubMed Web of Science ®Google Scholar
• Casiraghi F, Azzollini N, Todeschini M, et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant 2012;12(9):2373-83
   PubMed Web of Science ®Google Scholar
• Wu KH, Chan CK, Tsai C, et al. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 2011;91(12):1412-16
   PubMed Web of Science ®Google Scholar
• Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24(10):2292-8
   PubMed Web of Science ®Google Scholar
• Zhong YS, Lin N, Deng MH, et al. Deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver. Dig Dis Sci 2010;55(2):438-45
   PubMed Web of Science ®Google Scholar
• Mohamadnejad M, Alimoghaddam K, Bagheri M, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int 2013;33(10):1490-6
   PubMed Web of Science ®Google Scholar
• Terai S, Sakaida I, Yamamoto N, et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem 2003;134(4):551-8
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012;27(Suppl 2):112-20
   PubMed Web of Science ®Google Scholar
• Wang L, Li J, Liu H, et al. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2013;28(Suppl 1):85-92
   PubMed Web of Science ®Google Scholar
• Kemp K, Gray E, Wilkins A, Scolding N. Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum. Brain 2012;135(Pt 10):2962-72
   PubMed Web of Science ®Google Scholar
• Zhang MJ, Sun JJ, Qian L, et al. Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice. Brain Res 2011;1402:122-31
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells 2007;25(11):2896-902
   PubMed Web of Science ®Google Scholar
• Kuchroo P, Dave V, Vijayan A, et al. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a vegf-independent pathway. Stem Cells Dev 2015;24(4):437-50
   PubMed Web of Science ®Google Scholar
• Shen C, Lie P, Miao T, et al. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Mol Med Rep 2015;12(1):20-30
   Google Scholar
• Arno AI, Amini-Nik S, Blit PH, et al. Human Wharton’s jelly mesenchymal stem cells promote skin wound healing through paracrine signaling. Stem Cell Res Ther 2014;5(1):28
   PubMedGoogle Scholar
• Wei L, Zhang J, Xiao XB, et al. Multiple injections of human umbilical cord-derived mesenchymal stromal cells through the tail vein improve microcirculation and the microenvironment in a rat model of radiation myelopathy. J Transl Med 2014;12(1):246
   PubMed Web of Science ®Google Scholar
• Menge T, Gerber M, Wataha K, et al. Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/beta-catenin signaling pathway. Stem Cells Dev 2013;22(1):148-57
   PubMed Web of Science ®Google Scholar
• Han DM, Wang ZD, Ding L, et al. Effect of umbilical cord MSC infusion on the pulmonary infection in haploidentical hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2014;22(4):1084-8
   PubMedGoogle Scholar
• Sundin M, Orvell C, Rasmusson I, et al. Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual. Bone Marrow Transplant 2006;37(11):1051-9
   PubMed Web of Science ®Google Scholar
• Han ZX, Shi Q, Wang DK, et al. Basic biological characteristics of mesenchymal stem cells derived from bone marrow and human umbilical cord. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013;21(5):1248-55
   PubMedGoogle Scholar
• U-pratya Y, Manochantr SKheolamai P, Rojphisan S, et al. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton’s jelly and umbilical cord. Intern Med J 2013;43(4):430-9
   PubMed Web of Science ®Google Scholar
• Hass R, Kasper C, Bohm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell commun Signal 2011;9:12
   PubMed Web of Science ®Google Scholar
• Zhu SF, Zhong ZN, Fu XF, et al. Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells. Neurosci Lett 2013;541:77-82
   PubMed Web of Science ®Google Scholar
• Li X, Bai J, Ji X, et al. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med 2014;34(3):695-704
   PubMed Web of Science ®Google Scholar
• Ragni E, Vigano M, Parazzi V, et al. Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest. Intern J Biochem Cell Biol 2013;45(11):2456-66
   PubMed Web of Science ®Google Scholar
• Barlow S, Brooke G, Chatterjee K, et al. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 2008;17(6):1095-107
   PubMed Web of Science ®Google Scholar
• Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, et al. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 2009;11(2):163-76
   PubMed Web of Science ®Google Scholar
• Shaer A, Azarpira N, Aghdaie MH, Esfandiari E. Isolation and characterization of Human Mesenchymal Stromal Cells Derived from Placental Decidua Basalis; Umbilical cord Wharton’s Jelly and Amniotic Membrane. Pak J Med Sci 2014;30(5):1022-6
   Web of Science ®Google Scholar
• Castro-Manrreza ME, Mayani H, Monroy-Garcia A, et al. Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells. Stem Cells Dev 2014;23(11):1217-32
   PubMed Web of Science ®Google Scholar
• Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 2004;22(7):1330-7
   PubMed Web of Science ®Google Scholar
• Secunda R, Vennila R, Mohanashankar AM, et al. Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology 2014 10.1007/s10616-014-9718-z
   PubMedGoogle Scholar